Vancomycin Ophthalmic Ointment 1% for methicillin-resistant Staphylococcus aureus or methicillin-resistant Staphylococcus epidermidis infections: a case series

OBJECTIVES: To investigate the efficacy and safety of Vancomycin Ophthalmic Ointment 1% (Toa Pharmaceutical Co., Ltd, Toyama, Japan) in patients with external ocular infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or methicillin-resistant Staphylococcus epidermidis (MRSE). DE...

Descripción completa

Detalles Bibliográficos
Autores principales: Sotozono, Chie, Fukuda, Masahiko, Ohishi, Masao, Yano, Keiko, Origasa, Hideki, Saiki, Yoshinori, Shimomura, Yoshikazu, Kinoshita, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563129/
https://www.ncbi.nlm.nih.gov/pubmed/23364319
http://dx.doi.org/10.1136/bmjopen-2012-001206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563129/
https://www.ncbi.nlm.nih.gov/pubmed/23364319
http://dx.doi.org/10.1136/bmjopen-2012-001206

Ejemplares similares